Xencor, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACLX
Arcellx, Inc. |
$75.01 | $2.72 B | -49.3 | 163 | $107.94 M |
ANAB
AnaptysBio, Inc. |
$15.30 | $640.07 M | -3.82 | 136 | $91.28 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
ERAS
Erasca, Inc. |
$2.67 | $647.94 M | -2.83 | 126 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
IDYA
IDEAYA Biosciences, Inc. |
$25.69 | $2.88 B | -19 | 131 | $7.00 M |
KROS
Keros Therapeutics, Inc. |
$15.64 | $1.76 B | -9.45 | 169 | $3.55 M |
KURA
Kura Oncology, Inc. |
$8.51 | $1.66 B | -10.03 | 192 | $53.88 M |
LRMR
Larimar Therapeutics, Inc. |
$3.96 | $611.84 M | -9.99 | 42 | $0 |
MGTX
MeiraGTx Holdings plc |
$6.34 | $306.74 M | -4.01 | 389 | $33.28 M |
MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
MRUS
Merus N.V. |
$42.39 | $3.50 B | -19.38 | 260 | $36.13 M |
NUVL
Nuvalent, Inc. |
$78.09 | $5.11 B | -32.72 | 142 | $0 |
PCVX
Vaxcyte, Inc. |
$85.99 | $7.72 B | -16.54 | 414 | $0 |
PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
SNDX
Syndax Pharmaceuticals, Inc. |
$13.69 | $1.66 B | -6.02 | 270 | $23.68 M |
STRO
Sutro Biopharma, Inc. |
$2.04 | $303.46 M | -1.97 | 306 | $153.73 M |
VRDN
Viridian Therapeutics, Inc. |
$20.07 | $776.72 M | -2.71 | 143 | $302,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
